Schedule 13G ownership disclosure
CELLECT BIOTECHNOLOGY LTD
Security class unavailable · CUSIP: 15116C102
Event date: 2016-07-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 17.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-17-008892
- Form type
- SC 13G
- Filer
- Quoin Pharmaceuticals, Ltd.
- CIK
- CIK 1671502
- Filed
- Feb 14, 2017
- Reporting period
- Jul 28, 2016
- Description
- Schedule 13G beneficial ownership